Paul Laviolette
Director at Pulse Biosciences
Boston, Massachusetts
Overview
Work Experience
Chairman
2024 - Current
Spectrawave is a medical device company that develops optical diagnostic and therapeutic devices.
Raised $79,597,066.00 from Deerfield Management, Nova Ventures, Johnson & Johnson Innovation – JJDC, Heartwork Capital, S3 Ventures, SV Health Investors and Lumira Ventures.
CEO and Co-Chairman
2024
Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.
Raised $233,340,002.00 from Virginia Catalyst.
Managing Partner & Chief Operating Officer
2008
SV Health Investors is a boston-based venture capital firm focused on investments in biotechnology and healthcare industry.
Managing Partner
2020
Medtech Convergence Fund is the convergence of advanced materials science, component miniaturization, sensors and software.
Director
2022
Director
2022
Deerfield Catalyst is a premier medtech incubator founded to develop transformational medtech solutions.
Director
2020
Edwards Lifesciences is a provider of science of heart valves and hemodynamic monitoring.
Chairman
2016
Director
2016
CSA Medical is a provider of innovative spray cryotherapy medical device solutions.
Raised $159,045,664.00 from Blue Heron Capital, Ascension Ventures, TVM Capital Life Science, SV Health Investors, Tara Butler, Yonjin Venture, First Analysis and Intersouth Partners.
Chairman
2012